Dendrobine Alleviates Cellular Senescence and Osteoarthritis via the ROS/NF-κB Axis

• Published in: International journal of molecular sciences Vol. 24; no. 3; p. 2365
• Main Authors: Chen, Haitao, Tu, Ming, Liu, Siyi, Wen, Yinxian, Chen, Liaobin
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 25.01.2023; MDPI
• Subjects: Arthritis; Cartilage; Cartilage diseases; Cell cycle; Cells, Cultured; Cellular Senescence; chondrocyte senescence; Chondrocytes; Chondrocytes - metabolism; Computed tomography; Cyclin-dependent kinases; Cytotoxicity; Degradation; dendrobine; Extracellular matrix; Genotype & phenotype; Humans; IL-1β; Inflammation; Inflammation - metabolism; Interleukin-1beta - metabolism; Investigations; Joint diseases; Kinases; Mitochondria; NF-kappa B - metabolism; NF-κB pathway; NF-κB protein; Osteoarthritis; Osteoarthritis - metabolism; Oxidative stress; Phenotypes; reactive oxygen species; Reactive Oxygen Species - metabolism; Senescence; dendrobine; chondrocyte senescence; osteoarthritis; NF-κB pathway; reactive oxygen species
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24032365

Osteoarthritis (OA) is a degenerative joint disease characterized by low-grade inflammation and cartilage degradation. Dendrobine (DEN) is reported to inhibit inflammation and oxidative stress in some diseases, but its role in chondrocyte senescence and OA progress has not yet been elucidated. Our study aimed to explore the protective effects of DEN on OA both in vitro and in vivo. We found that DEN inhibited extracellular matrix (ECM) degradation and promoted ECM synthesis. Meanwhile, DEN inhibited senescence-associated secretory phenotype (SASP) factors expression and senescence phenotype in IL-1β-treated chondrocytes. Furthermore, DEN improved mitochondrial function and reduced the production of intracellular reactive oxygen species (ROS). Also, DEN suppressed IL-1β-induced activation of the NF-κB pathway. Further, using NAC (ROS inhibitor), we found that DEN might inhibit NF-κB cascades by reducing ROS. Additionally, X-ray, micro-CT, and histological analyses in vivo demonstrated that DEN significantly alleviated cartilage inflammation, ECM degradation, and subchondral alterations in OA progression. In conclusion, DEN inhibits SASP factors expression and senescence phenotype in chondrocytes and alleviated the progression of OA via the ROS/NF-κB axis, which provides innovative strategies for the treatment of OA.